Condition
Liver Graft Dysfunction
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Enrolling By Invitation1
Withdrawn1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06890234Enrolling By Invitation
Tissue Microdialysis Monitoring of Liver Grafts
NCT04841278Not ApplicableWithdrawnPrimary
Utility of Combined EUS and ERCP Procedures in the Evaluation of Liver Graft Dysfunction
NCT01781195UnknownPrimary
Delayed CNI-based Immunosuppression With Advagraf After MELD-based Liver Transplantation
Showing all 3 trials